I. Related cell sub types
ID | Name | Number of studies  | |
|---|---|---|---|
| CL_0000037 | hematopoietic stem cell | 18 | |
| CL_0000723 | somatic stem cell | 0 |
ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000037 | hematopoietic stem cell | 18 | |
| CL_0000723 | somatic stem cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| PRSS57 | 7 | 65% ± 24% | 0 | 5 | |
| HEMGN | 4 | 26% ± 6% | 0 | 2 | |
| AVP | 3 | 23% ± 8% | 0 | 0 | |
| TRIM58 | 3 | 36% ± 28% | 0 | 3 | |
| GATA1 | 3 | 20% ± 5% | 0 | 4 | |
| SPINK2 | 8 | 66% ± 9% | 1 | 3 | |
| CRHBP | 6 | 39% ± 10% | 1 | 3 | |
| FAM30A | 6 | 47% ± 7% | 1 | 6 | |
| NFE2 | 6 | 40% ± 14% | 1 | 10 | |
| MMRN1 | 4 | 29% ± 8% | 1 | 6 | |
| FAM117A | 4 | 41% ± 22% | 1 | 6 | |
| IGLL1 | 3 | 29% ± 10% | 1 | 5 | |
| FCER1A | 3 | 24% ± 3% | 1 | 8 | |
| MYCT1 | 3 | 17% ± 3% | 1 | 8 | |
| EREG | 6 | 32% ± 11% | 2 | 11 | |
| SLC39A3 | 4 | 25% ± 10% | 2 | 7 | |
| REC8 | 3 | 22% ± 0% | 2 | 4 | |
| FLT3 | 3 | 36% ± 14% | 2 | 4 | |
| CYTL1 | 7 | 37% ± 11% | 3 | 7 | |
| GNA15 | 6 | 39% ± 13% | 3 | 16 | |
| RAB37 | 6 | 31% ± 10% | 3 | 18 | |
| ANGPT1 | 5 | 33% ± 21% | 3 | 9 | |
| IL18 | 6 | 30% ± 7% | 3 | 20 | |
| TESPA1 | 5 | 27% ± 8% | 3 | 13 | |
| CSF3R | 5 | 40% ± 13% | 3 | 15 | |
| SPN | 8 | 45% ± 15% | 3 | 45 | |
| NPR3 | 4 | 47% ± 16% | 3 | 8 | |
| SMIM24 | 8 | 49% ± 10% | 4 | 14 | |
| CD34 | 7 | 47% ± 16% | 4 | 13 | |
| SMIM3 | 7 | 30% ± 12% | 4 | 15 |
| GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
| GO_0033631 | Biological process | cell-cell adhesion mediated by integrin |
| GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
| GO_1902255 | Biological process | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| GO_0032286 | Biological process | central nervous system myelin maintenance |
| GO_0051583 | Biological process | dopamine uptake involved in synaptic transmission |
| GO_0031118 | Biological process | rRNA pseudouridine synthesis |
| GO_0060385 | Biological process | axonogenesis involved in innervation |
| GO_0001562 | Biological process | response to protozoan |
| GO_0097294 | Biological process | 'de novo' XMP biosynthetic process |
| GO_0050904 | Biological process | diapedesis |
| GO_1904851 | Biological process | positive regulation of establishment of protein localization to telomere |
| GO_0014854 | Biological process | response to inactivity |
| GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
| GO_0006177 | Biological process | GMP biosynthetic process |
| GO_0045656 | Biological process | negative regulation of monocyte differentiation |
| GO_0090666 | Biological process | scaRNA localization to Cajal body |
| GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
| GO_0009642 | Biological process | response to light intensity |
| GO_0070495 | Biological process | negative regulation of thrombin-activated receptor signaling pathway |
| GO_0039529 | Biological process | RIG-I signaling pathway |
| GO_0006231 | Biological process | dTMP biosynthetic process |
| GO_0042775 | Biological process | mitochondrial ATP synthesis coupled electron transport |
| GO_0045906 | Biological process | negative regulation of vasoconstriction |
| GO_0006164 | Biological process | purine nucleotide biosynthetic process |
| GO_0000460 | Biological process | maturation of 5.8S rRNA |
| GO_0022898 | Biological process | regulation of transmembrane transporter activity |
| GO_0120317 | Biological process | sperm mitochondrial sheath assembly |
| GO_0031120 | Biological process | snRNA pseudouridine synthesis |
| GO_0045910 | Biological process | negative regulation of DNA recombination |
| Cell type name | hematopoietic stem cell |
| Synonyms | blood forming stem cell hemopoietic stem cell |
| Description | A stem cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. Hematopoietic stem cells lack cell markers of effector cells (lin-negative). Lin-negative is defined by lacking one or more of the following cell surface markers: CD2, CD3 epsilon, CD4, CD5 ,CD8 alpha chain, CD11b, CD14, CD19, CD20, CD56, ly6G, ter119. |
| Parent | CL_0000723 |
